Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
PaperCitations, authors & open-access status
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 318 citations, 2023 year and green oa status.
318
Citations
2023
Year
green
OA Status